A Pilot Study Of The Effects Of Microcurrent On Three Sleep Surveys

Completed · Phase 2

Conditions studied: Primary Insomnia

In brief

Participants identified as having primary insomnia will be randomly assigned to groups receiving microcurrent stimulation or sham in a double-blind randomized controlled trial. The microcurrent device used is FDA approved for the treatment of insomnia. The hypothesis is that the experimental group will have significantly improved scores on three sleep surveys after treatment while the sham group will not.

Key facts

Study ID

NCT00520832

Run by

Logan College of Chiropractic

People needed

20

Starts

2007-09-01

Expected to finish

2007-12-01

Last updated by the study team

2008-10-17

Who can join

Age: 18 and older, up to 40. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Student, Faculty or Staff
• Age 18 - 40
• Symptoms of primary insomnia

You may not qualify if…

• No implanted electric devices
• No local infection, injury or malignancy
• No history of seizure or other neurological disorders
• No current use of prescription or other substances that could effect sleep quality or quantity
• Pregnancy

Where it is running

• Logan College of Chiropractic — Chesterfield, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.